Body Dysmorphic Disorder: A Review of the Current Knowledge

Child Psychology and Psychiatry Review

Volumn 5, Issue 1, 2000, Pages 17-24

  Sobanski, Esther ^a   Schmidt, Martin H ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

aetiology; Body dysmorphic disorder; clinical features; comorbidity; treatment

Indexed keywords

EID: 85012458392     PISSN: 13606417     EISSN: 14753588     Source Type: Journal    
DOI: 10.1017/S1360641799009533     Document Type: Article

References (56)

1. American Psychiatric Association (1980). Diagnostic and statistical manual of mental disorders (3rd ed., DSM-III). Washington, DC: American Psychiatric Press.
2. American Psychiatric Association (1987). Diagnostic and statistical manual of mental disorders (3rd ed. revised, DSM-III-R). Washington, DC: American Psychiatric Press.
3. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th ed., DSM-IV). Washington, DC: American Psychiatric Press.
4. Andreassen, N. C., & Bardach, J. (1977). Dysmorphophobia: Symptom or disease? American Journal of Psychiatry, 134, 673–676.
5. Barr, L. C., Goodmann, W. K., & Price, L. H. (1992). Acute exacerbation of body dysmorphic disorder during tryptophan depletion. American Journal of Psychiatry, 149, 1406–1407.
6. Bloch, S., & Glue, P. (1988). Psychotherapy and dysmorphophobia: A case report. British Journal of Psychiatry, 152, 271–274.
7. Braddock, L. E. (1982). Dysmorphophobia in adolescence: A case report. British Journal of Psychiatry, 140, 199–201.
8. Connolly, F. H., & Gipson, M. (1978). Dysmorphophobia: A long term study. British Journal of Psychiatry, 132, 568–570.
9. Cotterill, J. A. (1981). Dermatological non-disease: A common and potentially fatal disturbance of cutaneous body-image. British Journal of Dermatology, 104, 611–619.
10. Craven, J. L., & Rodin, G. M. (1987). Cyproheptadine dependence associated with an atypical somatoform disorder. Canadian Journal of Psychiatry, 32, 143–145.
11. De Leon, J., Bott, A., & Simpson, G. M. (1989). Dysmor-phophobia: Body dysmorphic disorder or delusional disorder, somatic subtype? Comprehensive Psychiatry, 457–472
12. Fukuda, O. (1977). Statistical analysis of dysmorphophobia in outpatient clinic. Japanese Journal of Plastic and Reconstructive Surgery, 20, 569–577.
13. Goodmann, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., & Hill, C. (1989). The Yale-Brown-Obsessive-Compulsive Scale: Development, use and reliability. Archives of General Psychiatry, 46, 1006–1011.
14. Gomez-Perez, J. C., Marks, I. M., & Guirrez-Fissac, J. L. (1994). Dysmorphophobia: clinical features and outcome with behavior therapy. Behavioral Psychiatry, 9, 229–235.
15. Hardy, G. E., & Cotterill, J. A. (1982). Body image disturbances in dysmorphophobia. British Journal of Psychiatry, 141, 181–185.
16. Hay, G. G. (1970). Dysmorphophobia. British Journal of Psychiatry, 116, 399–406.
17. Hay, G. G. (1983). Paranoia and dysmorphophobia (letter). British Journal of Psychiatry, 142, 309–310.
18. Hollander, E., Cohen, L. J., & Simeon, D. (1993). Body dysmorphic disorder. Psychiatric Annals, 23, 359–364.
19. Hollander, E., Cohen, L. J., Simeon, D., Rosen, J., de Caria, C., & Stein, D. J. (1994). Fluvoxamine treatment of body dysmorphic disorder (letter). Journal of Clinical Psychopharmacology, 14, 77–78.
20. Hollander, E., Liebowitz, M. R., Winchel, R., Lumker, A., & Klein, D. F. (1998). Treatment of body-dysmorphic disorder with serotonin-reuptake blockers. American Journal of Psychiatry, 146, 768–770.
21. Jahrreis, W. (1930). Das hypochondrische Denken. Archiv der Psychiatrie und Nervenkrankheiten, 92, 686–923.
22. Janet, P. (1903). Less obsessions et la psychasthenie. Paris: Felix Alcan.
23. Jenike, M. A. (1984). A case report of successful treatment of dysmorphophobia with tranylcypromine. American Journal of Psychiatry, 141, 1463–1464.
24. Kraeplin, E. (1909). Psychiatrie (8th ed.) Leipzig: J. A. Barth.
25. Ladee, G. A. (1966). Hypochondrial syndromes. Amsterdam: Elsevier.
26. Marks, I. M. (1987). Fears, phobias and rituals. New York: Oxford University Press.
27. Marks, I. M., & Misham, J. (1988). Dysmorphophobic avoidance with disturbed bodily perception: A pilot study of exposure therapy. British Journal of Psychiatry, 152, 674–667.
28. McElroy, S. I., Phillips, K. A., & Keck, P. E. (1994). Obsessive compulsive spectrum disorder. Journal ofClinical Psychiatry, 55, 33–49.
29. McKay, D., Todaro, J., Neziroglu, F., Campisi, T., Moritz, E. K., & Yaryura-Tobias, J. A. (1997). Body dysmorphic disorder: A preliminary evaluation of treatment and maintenance using exposure with response prevention. Behavior Research and Therapy, 35, 67–70.
30. Morselli, E. (1886). Sulla dismorfofobia e sulla tafefobia. Bolletino della R accademia di Genova, 6, 110–119.
31. Munro, A., & Chmara, J. (1982). Monosymptomatic hypo-chondrial psychosis: A diagnostic checklist based on 50 cases of the disorder. Canadian Journal of Psychiatry, 27, 374–376.
32. Neziroglu, F. A., & Yaryura-Tobias, J. A. (1993). Exposure, response prevention and cognitive therapy in the treatment of body dysmorphic disorder. Behavior Therapy, 24, 431–438.
33. Philippopulos, G. S. (1979). The analysis of a case of dysmor-phophobia. Canadian Journal of Psychiatry, 24, 379–401.
34. Phillips, K. A. (1995). Body dysmorphic disorder. Clinical features and drug treatment. Practical Therapeutics, 3, 30–39.
35. Phillips, K. A. (1996a). Pharmacological treatment of body dysmorphic disorder. Pharmacological Bulletin, 32, 597–605.
36. Phillips, K. A. (1996b). The broken mirror: Understanding and treating Body Dysmorphic Disorder. New York: Oxford University Press.
37. Phillips, K. A. (1996c). An open study of buspirone augmentation of serotonin-reuptake inhibitors in body dysmorphic disorders. Psychopharmacological Bulletin, 32, 175–180.
38. Phillips, K. A., Atala, K., & Albertine, R. S. (1995). Case study: Body dysmorphic disorder in adolescents. Journal of American Academy of Child and Adolescent Psychiatry, 9, 1216–1220.
39. Phillips, K. A., & McElroy, S. L. (1996). Fluvoxamine in body dysmorphic disorder. Poster presented at the 149th annual meeting of the American Psychiatric Association, New York.
40. Phillips, K. A., McElroy, S. L., & Hudson, J. I. (1995). Body dysmorphic disorder: An obsessive-compulsive spectrum disorder, a form of affective spectrum disorder or both ? Journal of Clinical Psychiatry, 56, 41–51.
41. Phillips, K. A., McElroy, S., Keck, P., Hudson, J. I., & Pope, G. (1994). A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacology Bulletin, 2, 179–186.
42. Phillips, K. A., McElroy, S., Keck, P. E., Pope, H. G., & Hudson, J. I. (1993). Body dysmorphic disorder: 30 cases of imagined ugliness. American Journal of Psychiatry, 150, 302–308.
43. Pryse-Phillips, W. (1971). An olfactory reference syndrome. Acta Psychiatrica Scandinavica, 47, 484–509.
44. Rich, N., Rosen, J. C., & Orosan, P. G. (1992). Prevalence of body dysmorphic disorder in non-clinical populations. Presentation at Association for Advancement of Behavior Therapy, Boston.
45. Riding, J., & Munro, A. (1975). Pimozide in the treatment of monosymptomatic hypochondriacal psychosis. Acta Psychiatrica Scandinavica, 52, 23–30.
46. Rosen, J. C., & Reiter, J. (1996). Development of the Body Dysmorphic Disorder Examination. Behavior and Research Therapy, 43, 755–766.
47. Rosen, J. C., Reiter, J., & Orosan, P. (1995). Cognitive-behavioral body image therapy for body dysmorphic disorder. Journal of Consulting and Clinical Psychology, 63, 263–269.
48. Simeon, D., Hollander, E., Stein, D. J., Cohen, L., & Aronowitz, B. (1995). Body Dysmorphic Disorder in the DSM-IV field trial for obsessive-compulsive disorder. American Journal of Psychiatry, 152, 1207–1209.
49. Sobanski, E., & Schmidt, M. H. (in press). Everybody looks at my pubic bone: A case report of an adolescent patient with body dysmorphic disorder. Acta Psychiatrica Scandinavica.
50. Sondheimer, A. (1988). Clomipramine treatment of delusional disorder: Somatic type. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 188–192.
51. Thomas, C. S. (1984). Dysmorphophobia: a question of definition. British Journal of Psychiatry, 144, 513–516.
52. Thomas, C. S. (1985). Dysmorphophobia or monosymptomatic hypochondriasis ? (letter). British Journal of Psychiatry, 146, 672.
53. Veale, D., Boocook, A., Gournay, K., Dryden, W., Shah, F., Willson, R., & Walburn, J. (1996). Body Dysmorphic Disorder: A survey of fifty cases. British Journal of Psychiatry, 169, 196–201.
54. Veale, D., Gournay, W., Boocock, A., Shah, F., Wilson, R., & Walburn, J. (1996). Body Dysmorphic Disorder: A cognitive behavioral model and pilot randomised controlled trial. Behavior Research Therapy, 34, 717–729.
55. World Health Organisation (1992). The tenth revision of the International Classification of diseases and related health problems (ICD-10). Geneva: WHO.
56. Zaiden, S. H. (1950). Dermatologic hypochondriasis. A form of schizophrenia. Psychosomatic Medicine, 12, 250–253.